welcome
Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

Business

Business & Economics

In this article, we summarize the bulls’ thesis on GRAIL, Inc. (GRAL)

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
Summary
Nutrition label

77% Informative

GRAIL, Inc. ( GRAL )'s share was trading at $ 25.93 as of April 15th .

Grail is the undisputed leader in multi-cancer early detection (MCED) Its flagship product, Galleri , is a breakthrough blood test capable of detecting up to 50 types of cancer.

A successful Medicare rollout alone could drive $2.25 billion in sales, implying an $11 billion valuation at 5x sales.

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.